insights_auto
Bakit tumaas ang TNG 2.19%?
Tingnan ang Higit pang Detalyechevron_right
TNG:EPA
Transgene SA
€0.70
arrow_upward
+2.19%(+0.015) 1D
Okt 9, 5:35:10 PM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa TNG...
Buksan
€0.68
Mataas
€0.70
Mababa
€0.68
Mkt. cap
186.60M
Avg. na dami
138.90K
Dami
84.52K
Mataas nang 52-wk
€1.50
Mababa nang 52-wk
€0.68
EPS
-€0.17
Mga natitirang share
278.56M
Bilang ng mga empleyado
152
Buksan
€0.68
Mataas
€0.70
Mababa
€0.68
Mkt. cap
186.60M
Avg. na dami
138.90K
Dami
84.52K
Mataas nang 52-wk
€1.50
Mababa nang 52-wk
€0.68
EPS
-€0.17
Mga natitirang share
278.56M
Bilang ng mga empleyado
152
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
MarketBeat
·
16 minuto ang nakalipas
Priority Technology Holdings, Inc. (NASDAQ:PRTH) Stock Now Rated "Hold" by Wall Street Analysts
24/7 Wall St.
·
16 minuto ang nakalipas
Why "VOO and Chill" Lost Money for 8 Straight Years: What $100,000 in the S&P 500 Did From 2000 to 2008
Seeking Alpha
·
25 minuto ang nakalipas
S&P 500 Index Concentration - Room At The Top
Yahoo Finance
·
2 oras ang nakalipas
Should Twilio’s (TWLO) Inclusion in the S&P 500 Require Action From Existing Investors?
Profile
Transgene S.A. is a French biotechnology company founded in 1979. It is based in Illkirch-Graffenstaden, near Strasbourg, Alsace. The company develops and manufactures immunotherapies for the treatment of cancer. Based on viral vectors, these therapies stimulate the immune defenses of patients to specifically target cancer cells.
Transgene has two technological platforms based on these respective approaches: individual therapeutic vaccines, shared antigens cancer vaccines oncolytic viruses.
Transgene's portfolio consists of four products currently in clinical development. Its lead product TG4050, a neoantigen individualized therapeutic cancer vaccine is currently being developed in a randomized Phase I/II trial in the adjuvant treatment of head and neck cancer.
The company is listed on the regulated market of Euronext in Paris. Wikipedia
Tungkol sa Transgene SA